Trademark Filing
Capellon Pharmaceuticals, Ltd.
| Serial Number | 78392804 |
| Registration Number | 3131352 |
| Mark Drawing Code | 2000: Illustration: Drawing or design without any word(s)/letter(s)/ number(s) |
| Cancellation Code | 2 |
| Attorney Name | Stephen M. Roylance |
| Attorney Docket Number | T38027 |
| Law Office Assigned | M60 |
| Employee Name | DEFORD, JEFFREY S |
Timeline
| 2002-08-00 | Date of First Use |
| 2004-03-29 | Application Filed |
| 2006-01-11 | Amend to Register |
| 2006-07-03 | Location: PRE-PUBLICATION FINAL REVIEW |
| 2006-08-15 | Trademark Registered |
| 2013-03-22 | Cancelled |
| 2013-03-22 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Capellon Pharmaceuticals, Ltd. |
| Address | 7509 Flagstone Street Fort Worth TX US 76118 |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | US |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 010103 | Star |
| 100901 | Capsules, medicinal/nonmedicinal; Pills; Tablets, medicines; Tablets, nonmedical products in tablet form |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| DM0000 | The mark consists of a five pointed star pattern engraved into the upper surface of a pill. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2004-04-06 | 1 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2004-10-15 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2004-10-26 | 3 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2004-10-26 | 4 GNRT F:First Action |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2005-04-17 | 5 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2005-04-17 | 6 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2005-05-03 | 7 ACEC I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2005-06-28 | 8 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2005-06-28 | 9 GNFR O:Outgoing Correspondence |
| EXPARTE APPEAL RECEIVED AT TTAB | 2005-12-28 | 10 EXAF T:TTAB Proceeding |
| EX PARTE APPEAL-INSTITUTED | 2005-12-28 | 11 EXPI T:TTAB Proceeding |
| JURISDICTION RESTORED TO EXAMINING ATTORNEY | 2006-03-30 | 12 JURT T:TTAB Proceeding |
| APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | 2006-04-18 | 13 CNTA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2006-04-28 | 14 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2006-05-04 | 15 PREV O:Outgoing Correspondence |
| REGISTERED-SUPPLEMENTAL REGISTER | 2006-08-15 | 16 R.SR A:Allowance for Publication |
| EXPARTE APPEAL TERMINATED | 2006-08-15 | 17 EXPT T:TTAB Proceeding |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2010-04-22 | 18 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2010-04-22 | 19 ARAA I:Incoming Correspondence |
| CANCELLED SEC. 8 (6-YR) | 2013-03-22 | 20 C8.. O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 